Takeda Pharmaceutical has signed a strategic agreement with PvP Biologics that gives the corporate an option to acquire the University of Washington spinout.

Bpifrance has joined a consortium of investors that already featured Inserm Transfer Initiative and that previously provided $35m in funding.

Boehringer Ingelheim Venture Fund and Novo Seeds have co-led the liver disease therapy developer's latest round, which included HTGF, KfW, Coparion and EIF.

New strategic partner Northwell Health has added $1m to the telehealth technology startup's series A round, which includes NewYork-Presbyterian Hospital.

Intuity, a diabetes testing and management spinout of Sarnoff Corporation, has added $15m to the $40m it closed in November.

Seven members of digital health company iCarbonX's Digital Life Alliance have attracted almost $400m, with PatientsLikeMe raising $100m.

Illumina spinout Grail, developer of a blood test for cancer, has received expressions of interest worth about $1bn for its series B round.

The genome engineering company took its overall funding to approximately $50m in a series B round that included property developer Alexandria Real Estate Equities.